Macrolides confirmation

The relative and absolute stereochemistry of antimitotic macrolide archazolid A and B, originally isolated in the early nineties, has been determined on the basis of extensive high-field NMR studies, molecular modelling and chemical derivatization <06OL4751>. The proposed structures have yet to be confirmed by total synthesis. 

Results showed a total of 2.8% of the samples (n 2972) to be inhibitor positive by the Delvotest SP test further examination identified 1.7% as -lactam antibiotics, and 1.1 % as sulfonamides and dapsone. The percentage of chloramphenicol suspicious samples determined by the Charm II test was amazingly high however, tests for confirmation were not available and contamination of the samples by residues of the chloramphenicol-based preservative azidiol could not be excluded with certainty. Low concentrations of streptomycins were also detected in 5.7% of the samples (n 1221), but the MRL was not exceeded. Macrolide and tetracycline residues were not found in significant levels. Model trials with commercially applied yoghurt cultures confirmed how important the compliance to MRLs can be to dairy industry compared to antibiotic-free milk, a pH of 5.0 was reached with a delay of 15 min in the case of contamination with cloxacillin 30 min in the case of penicillin, spiramycin, and tylosin and 45 min in the case of oxytetracycline contamination. 

In Australia, the general antimicrobial screen is performed on kidney and is able to detect -lactam, aminoglycoside, tetracycline, and macrolide antimicrobials and to identify the class of antimicrobial compound present. Where the screen test identifies a class of compounds, confirmation and quantitation are done by the specific HPLC or gas chromatographic (GC) method appropriate for the class of antimicrobial. 

Most promising in terms of simplicity, selectivity, and sensitivity, for screening and even confirmation of macrolide residues in edible animal products, appear to be the methods described by Horie et al. (147) and Delepine et al. (150). 

B Delepine, D Hurtaud, P Sanders. Multiresidue method confirmation of macrolide antibiotics in bovine muscle by liquid chromatography-mass spectrometry. J AOAC Int 79 397-404, 1996. 

Confirming the above results, heating the carboxylic acid salts 384 and 385 (X=amidinium ion) for 1 min at their melting points (165° and 195°C respectively) gave a high yield of the 5-E, 9-E isomeric macrolide 386. Note again that, in the dioxolenium intermediate 387, the o — COO bond becomes anti-periplanar to the C9 - 0 bond and consequently the decarboxylation produces an E double-bond. 

All macrolides are regarded as relatively safe antibiotics whose principal side-effects are gastrointestinal disturbances ranging from mild upset to severe pain [281], Gastrointestinal motility in conscious dogs is not affected by 16-membered macrolides, in contrast to the substantial effects provoked by 14-membered macrolides [282-284]. These different effects on motility have recently been confirmed in clinical studies of miokamycin compared with several 14-membered macrolides [285, 286]. Less frequent side-effects such as hypersensitivity and cutaneous reactions have been mentioned [35, 287, 288]. 

Dubois et al. [59] determined the macrolides tylosin, tilmicoson, spiramycin, josamycin, and erythromycin in swine and bovine muscle, kidney and liver tissue, in bovine milk, and in hen eggs, using roxithromycin as IS. The method involves extraction in a Tris buffer, protein precipitation, SPE clean-up on a Oasis HLB cartridge, and LC-MS-MS analysis in SRM mode. All analytes were confirmed by four ions with an ion-ratio reproducibility ranging from 2.4 to 15%. The sample throughput is 50 samples per analyst per day. Draisci et al. [60] developed a confirmatory method for tylosin, tilmicosin, and erythromycin in bovine muscle, liver, and kidney. The quantification limits were 30, 20, and 50 pg/kg in mnscle, 40, 150, and 50 pg/kg in liver, and 40, 150, 80 pg/kg in kidney for tylosin, tilmicoson, and eiythromycin, respectively. Horie et al. [61] reported the multiresidne determination of erythromycin, oleandromycin, litasamycin, josamycin, mirosamycin, spiramycin, tilmicoson, and tylosin in meat and fish. The LOQ was 10 pg/kg in positive-ion LC-ESI-MS in SIM mode. 

For skin and soft tissue infections, roxithromycin is an effective and well-tolerated therapy for erysipelas and acne [162, 163]. As with other macrolide antibiotics, its immunomodulatory effects make it useful as an adjunctive therapy of psoriasis vulgaris [164]. Despite its in vitro activity against Borrelia burgdorferi, monotherapy with this macrolide was not effective for the treatment of Lyme borrelio-sis [165]. However, a small, nonrandomized, open prospective clinical study of 17 patients with confirmed late Lyme disease (stage n/III) showed a 76% complete recovery rate from a therapeutic combination of roxithromycin 300 mg... 

On the other hand, the inhibitory effect of erythromycin, a 14-membered-ring macrolide, on such a peptidyltransferase reaction is markedly diminished in terms of the character of a substrate. Erythromycin inhibits poly(A)-dependent polymerization of a transferred substrate such as lysine residue linked to tRNA but not other oligonucleotide-dependent polymerization of an amino acid linked either to tRNA or to oligonucleotides such as CACCA and UACCA. It has been shown that the transfer of A-acylaminoacyl residues to puromycin (puromycin reaction) is usually stimulated by erythromycin [88, 89, 95]. Igarashi et al. [96] have also confirmed these findings. That is to say, they found that erythromycin inhibits the release of a deacylated tRNA from the P site of ribosome. The release of such a deacylated tRNA from the P site and the translocation of peptidyl-tRNA from the A site to the P site of ribosome occurs concomitantly when EF-G catalyzes the GTP-dependent movement of the ribosome and the codon-anticodon-linked mRNA-peptidyl-tRNA complex. 

---